Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Research into a drug to reduce symptoms of inadvertent gluten exposure in people with coeliac disease has shown promising results

Researchers randomly assigned patients on a gluten-free diet to six injections of a monoclonal antibody, called AMG 714, over a 12-week period and found significant reductions in intestinal inflammation

Source  Biophoto Associates / Science Photo Library